Actinium Pharmaceuticals shows severe stockholders equity deterioration declining 76% while burning through substantial cash reserves.
The dramatic equity decline combined with meaningful cash burn raises immediate concerns about the company's financial stability and ability to fund ongoing operations. Despite modest improvements in operating losses and cash flow efficiency, the overall financial position has weakened substantially, which could impact the company's ability to advance its clinical pipeline without additional financing.
ATNM's financial position deteriorated significantly with stockholders equity collapsing 76% to just $7.8M while cash reserves declined 34% to $48.0M. The company did show some operational improvement with R&D expenses reduced 30% and operating losses narrowing modestly, along with more efficient cash utilization. However, the severe equity erosion overshadows these operational gains and signals potential going-concern issues for this clinical-stage biopharmaceutical company.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Cash declined 34.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Current assets declined 33.7% — monitor working capital adequacy and short-term liquidity.
Total assets contracted 32.7% — asset sales, write-downs, or balance sheet optimization underway.
R&D spending cut 29.7% — could signal cost discipline or concerning reduction in innovation investment.
Operating cash flow grew 25.7% — strong conversion of earnings to cash, healthy business fundamentals.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Net income grew 11.4% — bottom-line growth signals improving overall business health.
Revenue growing 11.1% — solid top-line momentum, watch margins for quality of growth.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →